MedPath

Renalytix AI, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Active, not recruiting
Conditions
Chronic Kidney Disease Stage 2
Chronic Kidney Disease Stage 1
Diabetic Kidney Disease
Chronic Kidney Diseases
Chronic Kidney Disease Stage 3
First Posted Date
2022-01-20
Last Posted Date
2024-04-12
Lead Sponsor
Renalytix AI, Inc.
Target Recruit Count
2000
Registration Number
NCT05198284
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mount Sinai Health System, New York, New York, United States

Prospective Decision Impact Trial of KidneyIntelX

Active, not recruiting
Conditions
Diabetic Kidney Disease
Chronic Kidney Disease Stage 1
Chronic Kidney Disease Stage 2
Chronic Kidney Disease, Stage 3 (Moderate)
First Posted Date
2021-07-14
Last Posted Date
2024-04-12
Lead Sponsor
Renalytix AI, Inc.
Target Recruit Count
2000
Registration Number
NCT04960514
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Atrium Health Wake Forest Baptist - Family Medicine - Piedmont Plaza, Winston-Salem, North Carolina, United States

Real World Evidence Clinical Utility Study of KidneyIntelX

Recruiting
Conditions
Diabetic Kidney Disease
Chronic Kidney Diseases
First Posted Date
2021-03-17
Last Posted Date
2024-04-12
Lead Sponsor
Renalytix AI, Inc.
Target Recruit Count
10000
Registration Number
NCT04802395
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mount Sinai Health System, New York, New York, United States

Decision Impact Trial of KidneyIntelX

Recruiting
Conditions
Diabetic Kidney Disease
First Posted Date
2021-03-10
Last Posted Date
2024-04-12
Lead Sponsor
Renalytix AI, Inc.
Target Recruit Count
1500
Registration Number
NCT04791358
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Delmar Family Medicine, Slingerlands, New York, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath